Compounds > ciprofloxacin

ciprofloxacin and clove

ciprofloxacin has been researched along with clove in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's2 (28.57)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Andrianasolo, D; Ramarokoto, H; Ramaroson, F; Rasolofo Razanamparany, V; Rasolonavalona, T; Ratsimba, L; Razafitsiarovana, I; Vincent, V1
Bercion, R; Cao, V; Fonkoua, MC; Ratsima, E; Richard, V; Talarmin, A; Van Tri, D1
Ralandison, S; Randriamboavonjy, R; Rapelanoro Rabenja, F1
Hong, E; Milenkov, M; Paranhos-Baccalà, G; Raberahona, M; Rakoto-Andrianarivelo, M; Rakotomahefa Narison, ML; Rakotovao, L; Ranaivo Rabetokotany, F; Randria, MJD; Rasoanandrasana, S; Taha, MK1
Aquino, PEA; Boligon, AA; Correia, FMA; Coutinho, HDM; Cristo, JS; Cunha, FAB; Ferreira, NMN; Guedes, MIF; Júnior, JGAS; Matias, EFF; Moura, FF; Nascimento, EM; Pereira, NLF; Silva, MKN; Vieira Filho, MA1
Andrianaivoarimanana, V; Baril, L; Bourner, J; Edwards, T; Gillesen, A; Horby, P; Legrand, A; Mangahasimbola, R; Mayouya-Gamana, T; Olliaro, P; Raberahona, M; Rajerison, M; Randremanana, RV; Randria, MJD; Randriamparany, R; Rasoanaivo, TF; Salam, A; Schoenhals, M1
Ferreira, MRA; Lima, LB; Machado, JCB; Napoleão, TH; Paiva, PMG; Santos, ECF; Silva, WAV; Soares, LAL1

Trials

1 trial(s) available for ciprofloxacin and clove

ArticleYear
An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial.
    Trials, 2020, Aug-17, Volume: 21, Issue:1

    Topics: Ciprofloxacin; Equivalence Trials as Topic; Female; Humans; Madagascar; Male; Plague; Streptomycin; Yersinia pestis

2020

Other Studies

6 other study(ies) available for ciprofloxacin and clove

ArticleYear
[A case of pulmonary multiresistant Mycobacterium bovis tuberculosis in Madagascar].
    Archives de l'Institut Pasteur de Madagascar, 2003, Volume: 69, Issue:1-2

    Topics: Amikacin; Antitubercular Agents; Capreomycin; Chronic Disease; Ciprofloxacin; Cough; DNA, Bacterial; Drug Therapy, Combination; Ethionamide; Humans; Kanamycin; Madagascar; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium bovis; Ofloxacin; Patient Compliance; Polymorphism, Restriction Fragment Length; Sputum; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2003
Antimicrobial susceptibility of Neisseria gonorrhoeae strains isolated in 2004-2006 in Bangui, Central African Republic; Yaoundé, Cameroon; Antananarivo, Madagascar; and Ho Chi Minh Ville and Nha Trang, Vietnam.
    Sexually transmitted diseases, 2008, Volume: 35, Issue:11

    Topics: Adult; Anti-Bacterial Agents; Cameroon; Ceftriaxone; Central African Republic; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Madagascar; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillinase; Spectinomycin; Vietnam

2008
[Treatment's problem of osteoarticular infections in Madagascar].
    Bulletin de la Societe de pathologie exotique (1990), 2009, Volume: 102, Issue:2

    Topics: Adult; Anti-Bacterial Agents; Arthritis, Infectious; Ceftriaxone; Ciprofloxacin; Developing Countries; Drug Therapy, Combination; Humans; Madagascar; Osteitis; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus

2009
Resurgence of Neisseria meningitidis serogroup W ST-11 (cc11) in Madagascar, 2015-2016.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2017, Volume: 55

    Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Typing Techniques; Cephalosporins; Ciprofloxacin; Disease Outbreaks; Female; Genotype; Humans; Incidence; Infant; Madagascar; Male; Meningococcal Infections; Molecular Epidemiology; Neisseria meningitidis

2017
In vitro evaluation of the antibacterial potential and modification of antibiotic activity of the Eugenia uniflora L. essential oil in association with led lights.
    Microbial pathogenesis, 2017, Volume: 110

    Topics: Anti-Bacterial Agents; Brazil; Chromatography, Gas; Ciprofloxacin; Drug Synergism; Escherichia coli; Eugenia; Light; Microbial Sensitivity Tests; Norfloxacin; Oils, Volatile; Staphylococcus aureus

2017
Eugenia uniflora: a promising natural alternative against multidrug-resistant bacteria.
    Brazilian journal of biology = Revista brasleira de biologia, 2023, Volume: 83

    Topics: Antioxidants; Bacteria; Ciprofloxacin; Eugenia; Gentamicins; Microbial Sensitivity Tests; Plant Extracts

2023